David Spaner

7.7k citations
123 papers · 4.7k indexed · 1 hit paper · h-index 35

Impact in

  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Virus-based gene therapy research
  • Immunology top 1%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology
    • Immunodeficiency and Autoimmune Disorders

Papers in

    • Chronic Lymphocytic Leukemia Research 57
    • Immune Cell Function and Interaction 21
    • Immunotherapy and Immune Responses 19
    • T-cell and B-cell Immunology 11

David Spaner

119 papers receiving 4.6k citations

Hit Papers

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells 2011 · 1.1k citations
1.1k20112026201620212505007501000

Peers

David Spaner
Comparison fields: 5 of 119
  • Genetics 1.4k
  • Immunology 1.8k
  • Oncology 1.9k
  • Pathology and Forensic Medicine 954
  • Hematology 554
Replace Steven H. Bernstein with:
Steven H. Bernstein United States
Kamal D. Puri United States
Alexander Egle Austria
Wei Xu China
Marc Schmitz Germany
D Delia Italy
Walter C. Darbonne United States
Junya Kuroda Japan
Cornelius Miething Germany
Alessandra Cesano United States
David Spaner relative to Steven H. Bernstein United States Steven H. Bernstein's profile →
Citations per field
00.5×1.6×
Steven H. Bernstein · 1×
Citations per year

Countries citing papers authored by David Spaner

Since Specialization
Citations

This map shows the geographic impact of David Spaner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Spaner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Spaner more than expected).

Fields of papers citing papers by David Spaner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Spaner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Spaner. The network helps show where David Spaner may publish in the future.

Co-authors

The 25 scholars most cited alongside David Spaner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Spaner Line = papers co-authored together David Spaner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.

#Work
1
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells
Hit paper breakdown →
20111136
2 2006314
3 2009231
4 1989120
5 2010109
6 2010108
7 201695
8 200385
9 201382
10 201279
11 200476
12 200675
13 201071
14 200567
15 201267
16 201665
17 199962
18
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
199961
19 200856
20 199853

About David Spaner

David Spaner is a scholar working on Genetics, Immunology, Pathology and Forensic Medicine, Oncology and Hematology, having authored 123 papers that have together received 4.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (57 papers), Lymphoma Diagnosis and Treatment (39 papers), Immune Cell Function and Interaction (21 papers), Immunotherapy and Immune Responses (19 papers), T-cell and B-cell Immunology (11 papers), Viral-associated cancers and disorders (10 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Genetics (1.4k citations), Immunology (1.8k citations), Oncology (1.9k citations), Pathology and Forensic Medicine (954 citations) and Hematology (554 citations). David Spaner has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Yonghong Shi, James N. Kochenderfer, Giao Q. Phan, Steven A. Rosenberg, Robert O. Carpenter, Richard M. Sherry, James C. Yang, Mark E. Dudley, Steven A. Feldman and Marybeth S. Hughes. Their work appears in journals such as Blood, The Journal of Immunology, Leukemia, Journal of Clinical Oncology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026